Evidence map›Paper›PMID 34686394›Full record

ArticleVaccine2021

Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States.

Emmanuelle A Dankwa, Christl A Donnelly, Andrew F Brouwer, Rui Zhao, Martha P Montgomery, Mark K Weng, Natasha K Martin

Abstract read
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Determining Herd Immunity Thresholds for Hepatitis A Virus Transmission to Inform Vaccination Strategies Among People Who Inject Drugs in 16 US States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Therapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emmanuelle A DankwaDepartment of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, UK. Electronic address: dankwa@stats.ox.ac.uk.
Christl A DonnellyDepartment of Statistics, University of Oxford, 24-29 St Giles', Oxford OX1 3LB, UK; MRC Centre for Global Infectious Disease Analysis, Imperial College London, St. Mary's Campus, Norfolk Place, London W2 1PG, UK.
Andrew F BrouwerDepartment of Epidemiology, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA.
Rui ZhaoLouisville Metro Department of Public Health and Wellness, 400 E Gray St, Louisville, KY 40202, USA.
Martha P MontgomeryDivision of Viral Hepatitis, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US12-3, Atlanta, GA 30329-4018, USA.
Mark K WengDivision of Viral Hepatitis, U.S. Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US12-3, Atlanta, GA 30329-4018, USA.
Natasha K MartinDivision of Infectious Diseases and Global Public Health, University of California San Diego, 9500 Gilman Drive, CA 92093, USA; Population Health Sciences, University of Bristol, Queens Road Bristol BS8 1QU, UK.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Modeling the Effects of the Environment on Enteric Pathogen DynamicsU01GM110712 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EISENBERG, JOSEPH N. S. · 2014 to 2018
$3.0M
Optimizing HIV prevention portfolios targeting people who inject drugs using dynamic economic modelingR01AI147490 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTIN, NATASHA · 2019 to 2022
$2.3M
CDC HHSMedical Research Council MR/R015600/1NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI147490NIGMS NIH HHS U01 GM110712
6 · The paper itself

Abstract

backgroundBetween September 2017 and June 2019, an outbreak of hepatitis A virus (HAV) occurred in Louisville, Kentucky, resulting in 501 cases and 6 deaths, predominantly among persons who experience homelessness or who use drugs (PEH/PWUD). The critical vaccination threshold (V

methodsTo determine which population subgroups had high infection risks, we employed a technique based on comparing the proportion of cases arising before and after the epidemic peak, across subgroups. We also developed a dynamic deterministic model of HAV transmission among PEH/PWUD to estimate the basic reproduction number (R

resultsOf the 501 confirmed or probable cases, 385 (76.8%) were among PEH/PWUD. Among PEH/PWUD and within the general population, homelessness was a significant risk factor for infection in the initial stages of the outbreak (odds ratios for homeless versus not homeless: 2.62; 95% confidence interval (CI): 1.62-4.25 for PEH/PWUD and 2.39; 95% CI: 1.51-3.78 for all detected cases). Our estimate for R

conclusionsVaccination coverage of at least 77% is likely required to prevent outbreaks of HAV among PEH/PWUD in Louisville, assuming a 90% vaccine efficacy. Proactive hepatitis A vaccination programs among PEH/PWUD will maximize health and economic benefits of these programs and reduce the likelihood of another outbreak.

Indexed as

Hepatitis AHepatitis A virusIll-Housed PersonsPharmaceutical PreparationsDisease OutbreaksHumansKentuckyUnited StatesVaccinationVaccine EfficacyPharmaceutical PreparationsCritical vaccination coverageDynamic modelingHepatitis AHerd immunityPersons who experience homelessness or who use drugs

Identifiers

PMID34686394
PMCPMC9128446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.